MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2022 International Congress

September 15-18, 2022. Madrid, Spain.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Conservative iron chelation for Neuroferritinopathy

    F. Marchand, C. Moreau, G. Kuchcinski, V. Huin, L. Defebvre, D. Devos (LILLE, France)

  • Contemporary study of the difficulties of late diagnostics in patients with Huntington’s disease in Uzbekistan

    G. Goyibova, S. Kuranbaeva, A. Umarov, S. Kalandarova (Tashkent, Uzbekistan)

  • Continuous circadian intracerebroventricular administration of anaerobically preserved dopamine greatly reduces severe L-dopa-related complications in Parkinson’s disease

    C. Moreau, P. Odou, A. Demailly, G. Touzet, N. Reyns, N. Carta, C. Barthelemy, D. Lannoy, B. Palas, B. Gouges, JC. Devedjian, L. Defebvre, M. Fisichella, D. Devos (Lille, France)

  • Continuous Dopaminergic Stimulation (CDS), different infusion rates

    L. Quirós Illán, L. Ruiz-Escribano Menchen, JP. Cabello, F. Villanueva, I. Martin, A. Garcia Maruenda, P. Nieto Palomares, RE. Ibañez, J. Vaamonde Gamo (Ciudad Real, Spain)

  • Continuous subcutaneous apomorphine infusion for the management of Parkinson’s disease at the end-of-life

    M. Bereau, M. Giffard, AL. Clairet, M. Verin, M. Auffret (Besançon, France)

  • Continuous wavelet transforms to improve the accuracy of motor assessments of Parkinson’s disease

    T. Kosuri, J. Brasic (Baltimore, USA)

  • Contribution of cognitive load to akinetic and trembling freezing of gait manifestations in patients with Parkinson’s disease

    P. Ginis, N. D'Cruz, D. Zoetewei, T. Herman, M. Gilat, J. Hausdorff, A. Nieuwboer (Leuven, Belgium)

  • Contribution of external globus pallidus to motor deficits of Parkinson’s disease: optogenetic studies in murine model

    S. Dibisceglie Caballero, A. Ces, F. Ambroggi, M. Amalric, A. Ouagazzal (Marseille, France)

  • Correlation between 3 Tesla Brain MRI Nigrosome-1 imaging and SPECT 123I-Ioflupane in parkinsonian disorders

    A. López-Jiménez, J. álvarez-Linera, JF. Boan, I. Pareés, M. Kurtis (Madrid, Spain)

  • Correlation between clinical scales and gait in Parkinson’s disease

    A. Bitiati, C. de Oliveira, R. Treza, S. Hondo, E. Angeles, C. Bernardo, L. de Oliveira, M. Carvalho, M. Golin, D. Coelho (Santo André, Brazil)

  • « Previous Page
  • 1
  • …
  • 36
  • 37
  • 38
  • 39
  • 40
  • …
  • 153
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley